Q/C Technologies, Inc. Convertible Preferred Stock Converted to Other Securities
Q/C Technologies, Inc. (QCLS) reported Convertible Preferred Stock Converted to Other Securities of $500.00 thousand for the 0-month period ending 2013-11-15, per its 10-Q filed 2014-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2014-08-12
- 2013-11-15: Convertible Preferred Stock Converted to Other Securities 0 month $500.00K.
| Period end | Convertible Preferred Stock Converted to Other Securities 0 month |
|---|---|
| 2013-11-15 | $500.00K 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |